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Abstract
IMPORTANCE Although strain on hospital capacity has been associated with increased mortality in
nonpandemic settings, studies are needed to examine the association between coronavirus disease
2019 (COVID-19) critical care capacity and mortality.
OBJECTIVE To examine whether COVID-19 mortality was associated with COVID-19 intensive care
unit (ICU) strain.
DESIGN, SETTING, AND PARTICIPANTS This cohort study was conducted among veterans with
COVID-19, as confirmed by polymerase chain reaction or antigen testing in the laboratory from March
through August 2020, cared for at any Department of Veterans Affairs (VA) hospital with 10 or more
patients with COVID-19 in the ICU. The follow-up period was through November 2020. Data were
analyzed from March to November 2020.
EXPOSURES Receiving treatment for COVID-19 in the ICU during a period of increased COVID-19 ICU
load, with load defined as mean number of patients with COVID-19 in the ICU during the patient’s
hospital stay divided by the number of ICU beds at that facility, or increased COVID-19 ICU demand,
with demand defined as mean number of patients with COVID-19 in the ICU during the patient’s stay
divided by the maximum number of patients with COVID-19 in the ICU.
MAIN OUTCOMES AND MEASURES All-cause mortality was recorded through 30 days after
discharge from the hospital.
RESULTS Among 8516 patients with COVID-19 admitted to 88 VA hospitals, 8014 (94.1%) were men
and mean (SD) age was 67.9 (14.2) years. Mortality varied over time, with 218 of 954 patients (22.9%)
dying in March, 399 of 1594 patients (25.0%) dying in April, 143 of 920 patients (15.5%) dying in May,
179 of 1314 patients (13.6%) dying in June, 297 of 2373 patients (12.5%) dying in July, and 174 of 1361
(12.8%) patients dying in August (P < .001). Patients with COVID-19 who were treated in the ICU
during periods of increased COVID-19 ICU demand had increased risk of mortality compared with
patients treated during periods of low COVID-19 ICU demand (ie, demand of 25%); the adjusted
hazard ratio for all-cause mortality was 0.99 (95% CI, 0.81-1.22; P = .93) for patients treated when
COVID-19 ICU demand was more than 25% to 50%, 1.19 (95% CI, 0.95-1.48; P = .13) when COVID-19
ICU demand was more than 50% to 75%, and 1.94 (95% CI, 1.46-2.59; P < .001) when COVID-19 ICU
demand was more than 75% to 100%. No association between COVID-19 ICU demand and mortality
was observed for patients with COVID-19 not in the ICU. The association between COVID-19 ICU load
and mortality was not consistent over time (ie, early vs late in the pandemic).
CONCLUSIONS AND RELEVANCE This cohort study found that although facilities augmented ICU
capacity during the pandemic, strains on critical care capacity were associated with increased
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Key Points
Question Is greater coronavirus disease
2019 (COVID-19) intensive care unit
(ICU) strain associated with increased
COVID-19 mortality?
Findings In this cohort study of 8516
patients with COVID-19 admitted to 88
US Veterans Affairs hospitals, strains on
critical care capacity were associated
with increased COVID-19 mortality.
Among patients with COVID-19, those
treated in the ICU during periods of peak
COVID-19 ICU demand had a nearly
2-fold increased risk of mortality
compared with those treated during
periods of low demand.
Meaning These findings suggest that
public health officials and hospital
administrators should consider
interventions that reduce COVID-19 ICU
demand to improve survival among
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Abstract (continued)
COVID-19 ICU mortality. Tracking COVID-19 ICU demand may be useful to hospital administrators and
health officials as they coordinate COVID-19 admissions across hospitals to optimize outcomes for
patients with this illness.
JAMA Network Open. 2021;4(1):e2034266. doi:10.1001/jamanetworkopen.2020.34266
Introduction
Health policy interventions (eg, social distancing) implemented to avoid overloading health care
systems have been associated with reduced coronavirus disease 2019 (COVID-19) hospitalization
rates.1,2 Hospital capacity strain resulting from increased patient volume or disease severity is
associated with increased mortality in nonpandemic settings.3 The association between COVID-19
critical care strain and mortality has not been examined. The objective of this study was to examine
the associations between 2 measures of intensive care unit (ICU) strain and mortality among patients
with COVID-19 who were admitted to a Department of Veterans Affairs (VA) facility.
Methods
This cohort study was approved by the Indiana University School of Medicine institutional review
board and the VA research and development committee at Richard L. Roudebush VA Medical Center.
This was an observational study without any direct patient contact and considered to be of minimal
risk; therefore, a waiver of informed consent was obtained. This study adheres to the Strengthening
the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
This observational cohort study included patients with polymerase chain reaction or antigen
test results positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from March 1
to August 31, 2020. We included patients admitted to a VA hospital that had 10 or more patients with
COVID-19 in the ICU during the study period. We excluded patients whose SARS-CoV-2 test date was
more than 2 days after admission. Follow-up extended through November 1, 2020.
Data from the VA Corporate Data Warehouse (CDW), including inpatient and outpatient data
files from the 2 years before the patient’s COVID-19 diagnosis through the day of admission, were
used to identify comorbid conditions, self-reported race/ethnicity, health care use, procedures
received, vital signs, and laboratory data.4,5 Death dates were obtained from the CDW, VA Vital
Status File, and patient’s electronic health record.6 The modified Acute Physiology, Age, Chronic
Health Evaluation (APACHE) III score7 was calculated at the time of hospital admission as a measure
of illness severity. Number of ICU beds was obtained from the VA Bed Management Solution
initiative. The number of ICU beds per facility described prepandemic ICU capacity, not any
augmented capacity that may have been implemented during the COVID-19 pandemic. Facility
complexity described the level of services provided at a VA facility, categorized as 1a, 1b, 1c, 2, or 3,
with level 1a being the most complex and level 3 being the least complex. Facility complexity included
ICU level, operative complexity level, patient clinical classification, teaching status characteristics,
amount of research funding, complex clinical programs provided (eg, invasive catheterization
laboratory, neurosurgery, and transplant), rurality, care provided in the community, and mental
health programs provided. The primary outcome was all-cause mortality. Patients were followed up
for 30 days after discharge.
Measures of COVID-19 ICU Strain
This study included 2 measures of COVID-19 critical care strain: ICU load and ICU demand; Figure 1
displays how these measures vary over time within an example facility. The COVID-19 ICU load
described how the caseload of patients with COVID-19 in the ICU compared with the typical ICU bed
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count at each facility. The COVID-19 ICU load was calculated at the patient level as the mean number
of patients with COVID-19 in the ICU during the patient’s hospital stay divided by the number of ICU
beds at that facility. The number of ICU beds at each facility was a fixed number. The COVID-19 ICU
load included only the number of patients with COVID-19 in the ICU, excluding patients with other
critical illnesses. The COVID-19 ICU load ranged from 0% to greater than 100%; it exceeded 100% if
the hospital increased critical care bed capacity during the pandemic (eg, by converting a sleep
laboratory into an ICU) and if those beds were occupied by patients with COVID-19.
The population of patients with COVID-19 in the ICU varied over time, with peak prevalence
rates occurring early (eg, March) at some hospitals and later (eg, July) at other hospitals. The
COVID-19 ICU demand described the caseload of patients with COVID-19 in the ICU when a patient
was treated compared with peak COVID-19 ICU caseload. It was calculated at the patient level as the
mean number of patients with COVID-19 in the ICU during the patient’s stay divided by the maximum
number of patients with COVID-19 in the ICU at that facility during the study period. The COVID-19
ICU demand ranged from 0% to 100%.
For example, if a hospital had 60 ICU beds before the pandemic and the mean number of
patients with COVID-19 in the ICU during a patient’s stay was 20, then the COVID-19 ICU load would
be 20 divided by 60, or 33%. If at that same facility the peak surge included 20 patients with
COVID-19 in the ICU and a patient was treated during the period when the mean of number patients
with COVID-19 in the ICU was 20, then the COVID-19 ICU demand would be 20 divided by 20,
or 100%.
Statistical Analysis
We described differences over time in baseline characteristics and mortality among inpatients with
COVID-19 using χ2 and Wilcoxon rank sum tests. We used Cox proportional hazard models to analyze
the time in days from admission to death, either in the hospital or within 30 days after discharge,
among patients who were admitted to the hospital (overall, in the general ward, and in the ICU).
Patients who were still in the hospital or out of the hospital and alive at 30 days after discharge were
treated as censored observations. We included a random effect for the facility to account for the
correlation of mortality among patients in the same hospital. Analyses were performed using SAS
Enterprise Guide statistical software version 7.11 (SAS Institute). P values were 2-sided, and statistical
significance was set at P < .05. Data were analyzed from March to November 2020.
Figure 1. Coronavirus Disease 2019 (COVID-19) Intensive Care Unit (ICU) Load and Demand


























March April May June July August
Patients with COVID-19 in the ICU
ICU beds
Maximum volume of patients
with COVID-19 in the ICU
COVID-19 ICU load exceeding
100% of ICU capacity 
Black solid vertical line with arrows indicates the
numbers at 1 time point used to calculate COVID-19 ICU
load, defined as the mean number of patients with
COVID-19 in the ICU during a patient’s hospital stay
divided by the number of ICU beds. Black dotted
vertical line indicates the numbers at 1 time point used
to calculate COVID-19 demand, defined as the mean
number of patients with COVID-19 in the ICU during a
patient’s hospital stay divided by the maximum
number of patients with COVID-19 in the ICU during
the study period. The results suggest that the risk of
mortality would be highest if a COVID-19 patient’s stay
was during the peak of ICU demand and if ICU caseload
approached or exceeded ICU bed capacity.
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Results
The cohort included 8516 patients with COVID-19 admitted to 88 VA hospitals (Figure 2); 8014
(94.1%) were men, and mean (SD) age was 67.9 (14.2) years. The observed mortality was 218 of 954
patients (22.9%) in March. It increased to 399 of 1594 patients (25.0%) in April, then decreased to
143 of 920 patients (15.5%) in May, leveling off at 179 of 1314 patients (13.6%) in June, 297 of 2373
patients (12.5%) in July, and 174 of 1361 patients (12.8%) in August (P < .001) (Table 1). The
proportion of patients ages 75 years or older fluctuated over time; 223 patients (23.4%) were in this
age group in March, increasing to 534 patients (33.5%) in April and 311 patients (33.8%) in May,
decreasing to 333 patients (25.3%) in June and 637 patients (26.8%) in July, and then increasing
again to 435 patients (32.0%) in August (P < .001). The proportion of patients receiving care on
general wards increased after the earliest months of the pandemic (March: 527 patients [55.2%];
April: 965 patients [60.5%]; May: 546 patients [59.3%]; June: 829 patients [63.1%]; July: 1603
patients [67.6%]; and August: 903 patients [66.3%]; P < .001). The COVID-19 ICU load and demand
changed over time. The proportion of patients with COVID-19 treated during periods of low COVID-19
ICU load (ie, 25%) increased over time, with 487 patients (51.0%) in March, 952 patients (59.7%)
in April, 785 patients (85.3%) in May, 1170 patients (89.0%) in June, 1923 patients (81.0%) in July,
and 1250 patients (91.8%) in August (P < .001). Similarly, the proportion of patients with COVID-19
treated during periods of peak COVID-19 ICU load (ie, >100%) decreased from 60 patients (6.3%) in
March to 18 patients (1.1%) in April, to 0 patients in May through August. The proportion of patients
with COVID-19 treated during periods of high COVID-19 ICU demand (ie, >75%) decreased during the
first 3 months of the pandemic, with 233 patients (24.4%) in March, 322 patients (20.2%) in April,
and 44 patients (4.8%) in May; increased to 142 patients (10.8%) in June and 413 patients (17.4%) in
July; then decreased to 79 patients (5.8%) in August (P < .001) (Table 1).
Patients with COVID-19 in the ICU treated during high COVID-19 ICU strain had increased risk of
mortality. Table 2 provides the unadjusted results, and Table 3 displays the adjusted hazard ratios
(HRs). Compared with patients with COVID-19 in the ICU treated during periods of low COVID-19 ICU
load (ie, 25%), the adjusted HR for all-cause mortality was 1.10 (95% CI, 0.88-1.37) for patients
treated during periods when COVID-19 ICU load was greater than 25% to 50%, 1.15 (95% CI,
0.81-1.64) when COVID-19 ICU load was greater than 50% to 75%, 1.67 (95% CI, 1.08-2.60) when
COVID-19 ICU load was greater than 75% to 100%, and 2.35 (95% CI, 1.25-4.39) when COVID-19 ICU
Figure 2. Patient Flow Diagram
48 013 US veterans with suspected COVID-19
47 666 With COVID-19
8977 Admitted at VA hospital with ≥10 ICU patients
8516 Included in the analytic sample
5275 Admitted to general wards (63.1%) 3143 Admitted to ICU (36.9%)
9636 Admitted at any VA hospital
347 Excluded because of negative
antibody tests
38 030 Excluded because they received
outpatient care only
659 Excluded because admitted at
VA hospitals with <10 ICU patients
461 Excluded with COVID-19 diagnosis
>2 days after admission
The figure displays the relative proportion of veterans
with coronavirus disease 2019 (COVID-19) who were
cared for in the general ward and intensive care
unit (ICU).
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Table 1. Baseline Characteristics and Mortality Over Time
Characteristic, No. (%)
Patients with COVID-19 by test date, No. (%)
P valueMarch (n = 954) April (n = 1594) May (n = 920) June (n = 1314) July (n = 2373) August (n = 1361)
Age, y
<65 412 (43.2) 499 (31.3) 275 (29.9) 564 (42.9) 952 (40.1) 472 (34.7)
<.001
65-74 319 (33.4) 561 (35.2) 334 (36.3) 417 (31.7) 784 (33.0) 454 (33.4)
75-84 147 (15.4) 306 (19.2) 173 (18.8) 207 (15.8) 410 (17.3) 269 (19.8)
≥85 76 (8.0) 228 (14.3) 138 (15.0) 126 (9.6) 227 (9.6) 166 (12.2)
Men 907 (95.1) 1518 (95.2) 872 (94.8) 1216 (92.5) 2228 (93.9) 1273 (93.5) .03
Race/ethnicity
African American 591 (61.9) 822 (51.6) 402 (43.7) 504 (38.4) 887 (37.4) 458 (33.7)
<.001Other or unknowna 54 (5.7) 88 (5.5) 62 (6.7) 115 (8.8) 199 (8.4) 116 (8.5)
White 309 (32.4) 684 (42.9) 456 (49.6) 695 (52.9) 1287 (54.2) 787 (57.8)
Primary care visit in prior 2 y 912 (95.6) 1479 (92.8) 834 (90.7) 1254 (95.4) 2243 (94.5) 1256 (92.3) <.001
COVID-19 ICU loadb
≤25% 487 (51.0) 952 (59.7) 785 (85.3) 1170 (89.0) 1923 (81.0) 1250 (91.8)
<.001
>25% to 50% 141 (14.8) 305 (19.1) 77 (8.4) 126 (9.6) 443 (18.7) 106 (7.8)
>50% to 75% 178 (18.7) 181 (11.4) 53 (5.8) 17 (1.3) 7 (0.3) 5 (0.4)
>75% to 100% 88 (9.2) 138 (8.7) 5 (0.5) 1 (0.1) 0 0
>100% 60 (6.3) 18 (1.1) 0 0 0 0
COVID-19 ICU demandc
≤25% 241 (25.3) 336 (21.1) 381 (41.4) 472 (35.9) 516 (21.7) 542 (39.8)
<.001
>25% to 50% 219 (23.0) 466 (29.2) 307 (33.4) 434 (33.0) 772 (32.5) 498 (36.6)
>50% to 75% 261 (27.4) 470 (29.5) 188 (20.4) 266 (20.2) 672 (28.3) 242 (17.8)
>75% 233 (24.4) 322 (20.2) 44 (4.8) 142 (10.8) 413 (17.4) 79 (5.8)
Hypertension 727 (76.2) 1272 (79.8) 706 (76.7) 970 (73.8) 1774 (74.8) 1023 (75.2) .002
Atrial fibrillation 127 (13.3) 302 (18.9) 174 (18.9) 191 (14.5) 362 (15.3) 231 (17.0) <.001
Smoking history
Never 336 (35.2) 449 (28.2) 248 (27.0) 480 (36.5) 780 (32.9) 442 (32.5)
<.001
Current 89 (9.3) 213 (13.4) 128 (13.9) 164 (12.5) 346 (14.6) 204 (15.0)
Former 420 (44.0) 661 (41.5) 364 (39.6) 546 (41.6) 1006 (42.4) 532 (39.1)
Unknown 109 (11.4) 271 (17.0) 180 (19.6) 124 (9.4) 241 (10.2) 183 (13.4)
BMI
<25 (reference) 193 (20.2) 451 (28.3) 274 (29.8) 307 (23.4) 555 (23.4) 328 (24.1)
<.001
25-29 271 (28.4) 481 (30.2) 278 (30.2) 405 (30.8) 702 (29.6) 416 (30.6)
30-34 260 (27.3) 339 (21.3) 194 (21.1) 315 (24.0) 573 (24.1) 323 (23.7)
≥35 218 (22.9) 300 (18.8) 146 (15.9) 267 (20.3) 513 (21.6) 265 (19.5)
Missing data 12 (1.3) 23 (1.4) 28 (3.0) 20 (1.5) 30 (1.3) 29 (2.1)
Place of treatment
General ward 527 (55.2) 965 (60.5) 546 (59.3) 829 (63.1) 1603 (67.6) 903 (66.3)
<.001
ICU
No ventilation 195 (20.4) 367 (23.0) 251 (27.3) 346 (26.3) 536 (22.6) 341 (25.1)
Mechanical ventilation 232 (24.3) 262 (16.4) 123 (13.4) 139 (10.6) 234 (9.9) 117 (8.6)
APACHE score, median (IQR)d 12 (6-21) 13 (6-22) 12 (5-20) 10 (4-17) 10 (4-19) 10 (4-18) <.001
Charlson comorbidity index,
median (IQR)e
3 (1-6) 3 (1-6) 3 (1-6) 2 (1-5) 3 (1-5) 3 (1-5) <.001
Died 218 (22.9) 399 (25.0) 143 (15.5) 179 (13.6) 297 (12.5) 174 (12.8) <.001
Abbreviations: APACHE, Acute Physiology, Age, Chronic Health Evaluation; BMI, body
mass index (calculated as weight in kilograms divided by height in meters squared);
COVID-19, coronavirus disease 2019; ICU, intensive care unit; IQR, interquartile range.
a Other includes Hispanic or Latino, Asian, Native Hawaiian or other Pacific Islander,
American Indian or Alaskan Native, or other race/ethnicity.
b Calculated as mean No. of patients with COVID-19 in the ICU during stay divided by No.
of ICU beds.
c Calculated as mean No. of patients with COVID-19 in the ICU during stay divided by
maximum No. of patients with COVID-19 in the ICU.
d A physiologic measure in which increasing scores indicate worse health. This score
includes laboratory data (eg, white blood cell count) as well as vital signs (eg,
oxygenation and blood pressure).
e A measure of medical comorbidity in which increasing values indicate a greater
comorbidity burden.
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load was 100% or more (P = .049). The association between COVID-19 ICU load and mortality among
patients treated in the general ward was statistically significant but did not form a monotonic
gradient; the adjusted HR for all-cause mortality was 1.30 (95% CI, 0.92-1.84) for patients treated
during periods when COVID-19 ICU load was greater than 25% to 50%, 0.74 (95% CI, 0.42-1.32)
when COVID-19 ICU load was greater than 50% to 75%, 1.90 (95% CI, 0.98-3.65) when COVID-19 ICU
load was greater than 75% to 100%, and 1.14 (95% CI, 0.29-4.49) when COVID-19 ICU load was
100% or more (P = .04).
Compared with patients with COVID-19 in the ICU treated during periods of low COVID-19 ICU
demand (ie, 25%), the adjusted HR for all-cause mortality was 0.99 (95% CI, 0.81-1.22; P = .93) for
patients treated during periods when COVID-19 ICU demand was greater than 25% to 50%, 1.19
(95% CI, 0.95-1.48 P = .13) when COVID-19 ICU demand was greater than 50% to 75%, and 1.94 (95%
CI, 1.46-2.59; P < .001) when COVID-19 ICU demand was greater than 75% to 100%. No statistically
significant association between COVID-19 ICU demand and mortality was observed among patients
with COVID-19 who were not in the ICU. The eTable in the Supplement provides the adjusted HRs
for the 2 measures of COVID-19 ICU strain early in the pandemic (ie, March-May 2020) and later in
the pandemic (ie, June-August 2020), and these data are consistent with overall study findings.
Discussion
In this cohort study of patients with COVID-19 in US VA hospitals, receiving treatment during peak
COVID-19 ICU demand, with demand describing the caseload of patients with COVID-19 in the ICU
when the patient was treated compared with peak COVID-19 ICU caseload, was consistently and
independently associated with COVID-19 ICU mortality. In the extreme case, the adjusted hazard of
death was 1.94 for patients with COVID-19 treated in the ICU during periods with greater than 75% to
100% of the peak COVID-19 ICU caseload. The finding that COVID-19 ICU demand was associated
with increased mortality for patients with critical COVID-19 early in the pandemic (ie, March-May) and
later in the pandemic (ie, June-August) supports the overall study results that suggested that strains
on critical care capacity were associated with increased COVID-19 ICU mortality.
Tracking COVID-19 ICU demand may be useful to hospital administrators and health officials as
they seek to implement interventions to optimize outcomes for patients with COVID-19.8 COVID-19
ICU demand can be calculated only retrospectively (because the peak number of patients with
COVID-19 in the ICU can be assessed only retrospectively). However, facilities can identify the peak
surge caseload since the pandemic started, in March 2020, and prospectively monitor COVID-19 ICU
demand. Facilities within a health care system or within a geographic region could collaborate to
triage patients with critical COVID-19 to sites with greater ICU capacity to reduce strain on any 1
facility.9,10 Future research is urgently needed to investigate the mechanisms by which COVID-19 ICU
Table 2. Unadjusted Mortality by COVID-19 ICU Strain Metrics
ICU strain at patient level
COVID-19 mortality through 30 d postdischarge, No./total No. (%)
Overall General ward only ICU
COVID-19 ICU loada
≤25% 950/6567 (14.5) 313/4303 (7.3) 637/2264 (28.1)
>25% to 50% 259/1198 (21.6) 75/662 (11.3) 184/536 (34.3)
>50% to 75% 96/441 (21.8) 22/233 (9.4) 74/208 (35.6)
>75% to 100% 79/232 (34.0) 28/132 (21.2) 51/100 (51.0)
>100% 26/78 (33.3) 3/43 (7.0) 23/35 (65.7)
COVID-19 ICU demandb
≤25% 281/2488 (11.3) 116/1815 (6.4) 165/673 (24.5)
>25% to 50% 429/2696 (15.9) 145/1683 (8.6) 284/1013 (28.0)
>50% to 75% 443/2099 (21.1) 106/1107 (9.6) 337/992 (34.0)
>75% 257/1233 (20.8) 74/768 (9.6) 183/465 (39.4)
Abbreviations: COVID-19, coronavirus disease 2019;
ICU, intensive care unit.
a Calculated as No. patients with COVID-19 in the ICU
during stay divided by No. of ICU beds.
b Calculated as mean No. of patients with COVID-19 in
the ICU during stay divided by maximum No. of
patients with COVID-19 in the ICU.
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Table 3. Proportional Hazard Results From Admission to 30 Days Postdischarge or Death
Characteristic
Overall General ward only ICU








65-74 2.10 (1.75-2.52) 2.35 (1.55-3.57) 2.08 (1.70-2.55)
75-84 3.04 (2.50-3.69) 4.79 (3.15-7.29) 2.73 (2.18-3.42)
≥85 6.85 (5.59-8.39) 11.15 (7.33-16.97) 5.39 (4.20-6.92)
Women 0.86 (0.60-1.25) .44 0.68 (0.32-1.46) .32 0.97 (0.63-1.48) .88
Race/ethnicity





.11Other or unknowna 1.01 (0.81-1.26) 0.93 (0.64-1.36) 1.02 (0.78-1.34)
White 1 [Reference] 1 [Reference] 1 [Reference]








>25% to 50% 1.19 (0.99-1.43) 1.30 (0.92-1.84) 1.10 (0.88-1.37)
>50% to 75% 1.03 (0.77-1.40) 0.74 (0.42-1.32) 1.15 (0.81-1.64)
>75% to 100% 1.63 (1.13-2.35) 1.90 (0.98-3.65) 1.67 (1.08-2.60)








>25% to 50% 1.11 (0.94-1.31) 1.41 (1.07-1.84) 0.99 (0.81-1.22)
>50% to 75% 1.25 (1.05-1.49) 1.30 (0.95-1.79) 1.19 (0.95-1.48)
>75% 1.67 (1.33-2.11) 1.29 (0.85-1.97) 1.94 (1.46-2.59)
Hypertension 0.94 (0.80-1.11) .46 0.92 (0.68-1.24) .55 0.94 (0.77-1.14) .51








Current 0.70 (0.56-0.87) 0.73 (0.47-1.14) 0.74 (0.57-0.96)
Former 0.93 (0.81-1.06) 0.98 (0.77-1.26) 0.92 (0.78-1.08)








25-29 0.83 (0.72-0.95) 0.75 (0.59-0.94) 0.88 (0.74-1.05)
30-34 0.80 (0.68-0.94) 0.72 (0.53-0.97) 0.84 (0.69-1.02)
≥35 0.94 (0.79-1.11) 0.96 (0.68-1.36) 0.98 (0.79-1.20)
Missing data 1.38 (0.97-1.98) 1.65 (0.92-2.93) 1.39 (0.87-2.22)
Place of treatment







No ventilation 1.93 (1.66-2.24) NA 1 [Reference]
Mechanical ventilation 7.40 (6.47-8.48) NA 3.93 (3.39-4.55)
APACHE scored 1.02 (1.02-1.03) <.001 1.04 (1.03-1.05) <.001 1.02 (1.01-1.02) <.001
Charlson comorbidity scoree 1.05 (1.03-1.06) <.001 1.09 (1.06-1.12) <.001 1.02 (1.00-1.05) .03







April 1.47 (1.20-1.79) 1.48 (1.04-2.10) 1.52 (1.19-1.96)
May 1 [Reference] 1 [Reference] 1 [Reference]
June 1.15 (0.91-1.45) 1.11 (0.74-1.68) 1.22 (0.91-1.62)
July 1.05 (0.85-1.30) 0.83 (0.57-1.20) 1.23 (0.94-1.61)
August 1.23 (0.97-1.55) 0.84 (0.56-1.26) 1.50 (1.13-2.00)
(continued)
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demand may be associated with increased mortality; it is imperative that we understand the degree
to which patient characteristics (eg, disease severity) or facility issues (eg, staffing) contribute to the
association between COVID-19 ICU strain and poor patient outcomes among patients with critical
COVID-19.
We did not have a formal measure of ICU capacity, because VA ICU bed availability is not fixed
but instead depends on staffing availability; therefore, we calculated COVID-19 ICU load as the ratio
of ICU COVID-19 occupancy to the maximum ICU bed number as a surrogate for COVID-19 ICU
capacity. Although the association between COVID-19 ICU load and patient mortality was statistically
significant, it was neither as consistent over time nor as robust as the association between COVID-19
ICU demand and mortality. We hypothesize that facilities increased their critical care capacity in
response to the pandemic and that the degree of this augmentation varied across facilities.
Therefore, the comparison with a fixed number of patient beds was likely a relatively poor measure
of ICU capacity during the pandemic. Given that hospitals are charged with caring for patients with
non–COVID-19 critical illness as well as patients with COVID-19, future studies should seek to examine
whether measures of critical care strain that include all patients in the ICU (not just those with
COVID-19) are associated with patient outcomes. Future studies should also evaluate whether ICU
load provides an adequate measure of strain across the broad spectrum of VA and non-VA hospitals,
which vary greatly in prepandemic ICU bed number and the potential to augment capacity during a
pandemic. Our overall study findings are supported by cohort studies from 201311 and 201812
demonstrating that as ICUs are strained, mortality increases.11,12
It may be the case that during periods of peak ICU caseload, patients who would be admitted to
the ICU under more typical conditions are instead admitted to the ward.13 Our data did not allow us
to examine this issue directly; however, we did examine outcomes associated with COVID-ICU strain
separately among patients in the general ward and patients in the ICU. Although the association
between COVID-19 ICU load and general ward mortality was statistically significant, it varied over
time (ie, early vs later in the pandemic). Future research should examine how critical care strains may
be associated with outcomes in the general ward for patients with COVID-19 and those without
COVID-19.
Table 3. Proportional Hazard Results From Admission to 30 Days Postdischarge or Death (continued)
Characteristic
Overall General ward only ICU








1b 0.94 (0.59-1.51) 1.29 (0.48-3.47) 0.82 (0.47-1.41)
1c 1.29 (0.81-2.07) 1.50 (0.56-4.04) 1.17 (0.68-2.02)
2 1 [Reference] 1 [Reference] 1 [Reference]
Abbreviations: APACHE, Acute Physiology, Age, Chronic Health Evaluation; BMI, body
mass index (calculated as weight in kilograms divided by height in meters squared);
COVID-19, coronavirus disease 2019; HR, hazard ratio; ICU, intensive care unit; NA, not
applicable.
a The other race/ethnicity category includes Hispanic or Latino, Asian, Native Hawaiian
or other Pacific Islander, American Indian or Alaskan Native, or other race/ethnicity.
b Calculated as No. patients with COVID-19 in the ICU during stay divided by No. of
ICU beds.
c Calculated as mean No. of patients with COVID-19 in the ICU during stay divided by
maximum No. of patients with COVID-19 in the ICU.
d A physiologic measure in which increasing scores indicate worse health. This score
includes laboratory data (eg, white blood cell count) as well as vital signs (eg,
oxygenation and blood pressure).
e A measure of medical comorbidity in which increasing values indicate a greater
comorbidity burden.
f The complexity of the services provided at Veterans Affairs facilities, with level 1a being
the most complex. The facility complexity model includes ICU level, operative
complexity level, patient clinical classification, teaching status characteristics, amount
of research funding, complex clinical programs provided (eg, invasive catheterization
laboratory, neurosurgery, or transplant), rurality, care provided in the community, and
mental health programs provided.
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Limitations
This study has several limitations. First, this study evaluated care of patients with COVID-19 at VA
hospitals; future studies should examine the association between COVID-19 ICU burden and
mortality in non-VA facilities. Second, this study focused on COVID-19 mortality; future studies should
examine the potential associations of COVID-19 ICU load and demand with outcomes among patients
without COVID-19. Third, the results of this study should not be interpreted as a statement on
scarcity of critical care or mechanical ventilation; we have no data to suggest that patients needing
critical care or mechanical ventilation did not receive this care.14 Fourth, although the risk adjustment
models included demographic and clinical characteristics, they did not include social determinants
of health (eg, income or education), which may contribute to COVID-19 mortality. Fifth, we did not
examine changes in ICU staffing during the study period. Sixth, we do not have a measure of the
degree to which facilities expanded ICU capacity during the pandemic. Seventh, patients with
COVID-19 who were admitted to the ICU service could have physically been in diverse settings,
including locations designated as the COVID-19 ICU, such as surgical ICUs; some patients with critical
COVID-19 were cared for by the ICU team but were physically located in the emergency department.
Eighth, related to the observed change in mortality over time, our results suggest that changes in
patient characteristics and measures of COVID-19 ICU strain were associated with some of the
variation in mortality over time; however, given the observational nature of these data, causality
cannot be inferred. Other potential causes (eg, use of medications, such as remdesivir and
dexamethasone; clinical practices, such as proning; and unmeasured changes in patient
characteristics, such as susceptibility) may have contributed to changes in COVID-19 mortality.15
Conclusions
In this cohort study of patients with COVID-19 in US VA hospitals, COVID-19 ICU demand—a measure
of COVID-19 ICU caseload when a patient was treated compared with peak COVID-19 ICU
caseload—was associated with mortality among patients with COVID-19 in the ICU. Public health
officials and hospital administrators may seek to prevent high COVID-19 ICU demand to optimize
outcomes for patients with COVID-19.
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